Unfractioned heparin for treatment of sepsis: A randomized clinical trial (The HETRASE Study)*

Abstract

Our findings suggested that UFH may be a feasible and safe intervention in sepsis. However, this study was not able to demonstrate a beneficial effect on the chosen primary outcomes or in the 28-day mortality rate.